Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3746-3756

  Usami, Yoshiko ^a   Popov, Sergei ^a   Weiss, Eric R ^a   Vriesema Magnuson, Christie ^a   Calistri, Arianna ^b,c   Göttlinger, Heinrich G ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CHARGED MULTIVESICULAR BODY PROTEIN 4; ESCRT PROTEIN; PROTEIN ALIX; PROTEIN CC2D1A; PROTEIN CC2D1B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; VIRUS INHIBITION; VIRUS RELEASE;

CELL LINE; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; VIRUS RELEASE;

DROSOPHILA MELANOGASTER; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84861324351     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06539-11     Document Type: Article

References (59)

1. Bajorek M, et al. 2009. Structural basis for ESCRT-III protein autoinhibition. Nat. Struct. Mol. Biol. 16: 754-762.
2. Baumgartel V, et al. 2011. Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component. Nat. Cell Biol. 13: 469-474.
3. Bieniasz PD. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5: 550-558.
4. Caballe A, Martin-Serrano J. 2011. ESCRT machinery and cytokinesis: the road to daughter cell separation. Traffic 12: 1318-1326.
5. Carlton JG, Martin-Serrano J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316: 1908-1912.
6. Chang CH, et al. 2011. TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways. J. Biol. Chem. 286: 7043-7051.
7. Chesebro B, Wehrly K, Nishio J, Perryman S. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66: 6547-6554.
8. Childress JL, Acar M, Tao C, Halder G. 2006. Lethal giant discs, a novel C2-domain protein, restricts notch activation during endocytosis. Curr. Biol. 16: 2228-2233.
9. Demirov DG, Freed EO. 2004. Retrovirus budding. Virus Res. 106: 87-102.
10. Demirov DG, Ono A, Orenstein JM, Freed EO. 2002. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99: 955-960.
11. Dussupt V, et al. 2009. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog. 5: e1000339.
12. Fabrikant G, et al. 2009. Computational model of membrane fission catalyzed by ESCRT-III. PLoS Comput. Biol. 5: e1000575.
13. Fisher RD, et al. 2007. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128: 841-852.
14. Fujii K, Hurley JH, Freed EO. 2007. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat. Rev. Microbiol. 5: 912-916.
15. Fujii K, et al. 2009. Functional role of Alix in HIV-1 replication. Virology 391: 284-292.
16. Gallagher CM, Knoblich JA. 2006. The conserved c2 domain protein lethal (2) giant discs regulates protein trafficking in Drosophila. Dev. Cell 11: 641-653.
17. Garrus JE, et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65.
18. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88: 3195-3199.
19. Hadjighassem MR, Galaraga K, Albert PR. 2011. Freud-2/CC2D1B mediates dual repression of the serotonin-1A receptor gene. Eur. J. Neurosci. 33: 214-223.
20. Hanson PI, Roth R, Lin Y, Heuser JE. 2008. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J. Cell Biol. 180: 389-402.
21. Henne WM, Buchkovich NJ, Emr SD. 2011. The ESCRT pathway. Dev. Cell 21: 77-91.
22. Hurley JH. 2010. The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 45: 463-487.
23. Jaekel R, Klein T. 2006. The Drosophila Notch inhibitor and tumor suppressor gene lethal (2) giant discs encodes a conserved regulator of endosomal trafficking. Dev. Cell 11: 655-669.
24. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. 2011. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat. Cell Biol. 13: 394-401.
25. Katoh K, Shibata H, Hatta K, Maki M. 2004. CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms. Arch. Biochem. Biophys. 421: 159-165.
26. Kieffer C, et al. 2008. Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Dev. Cell 15: 62-73.
27. Kondo E, Gottlinger HG. 1996. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J. Virol. 70: 159-164.
28. Langelier C, et al. 2006. Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J. Virol. 80: 9465-9480.
29. Lata S, et al. 2008. Structural basis for autoinhibition of ESCRT-III CHMP3. J. Mol. Biol. 378: 816-825.
30. Lata S, et al. 2008. Helical structures of ESCRT-III are disassembled by VPS4. Science 321: 1354-1357.
31. Lee S, Joshi A, Nagashima K, Freed EO, Hurley JH. 2007. Structural basis for viral late-domain binding to Alix. Nat. Struct. Mol. Biol. 14: 194-199.
32. Martin-Serrano J, Neil SJ. 2011. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 9: 519-531.
33. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD. 2003. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 100: 12414-12419.
34. Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7: 1313-1319.
35. Matsuda A, et al. 2003. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318.
36. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP. 2008. ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl. Acad. Sci. U. S. A. 105: 7687-7691.
37. Morita E, et al. 2010. Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc. Natl. Acad. Sci. U. S. A. 107: 12889-12894.
38. Morita E, et al. 2007. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26: 4215-4227.
39. Morita E, et al. 2011. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9: 235-242.
40. Muziol T, et al. 2006. Structural basis for budding by the ESCRT-III factor CHMP3. Dev. Cell 10: 821-830.
41. Nakamura A, Arai H, Fujita N. 2009. Centrosomal Aki1 and cohesin function in separase-regulated centriole disengagement. J. Cell Biol. 187: 607-614.
42. Nakatani Y, Ogryzko V. 2003. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370: 430-444.
43. Popov S, Popova E, Inoue M, Gottlinger HG. 2008. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 82: 1389-1398.
44. Rogaeva A, Galaraga K, Albert PR. 2007. The Freud-1/CC2D1A family: transcriptional regulators implicated in mental retardation. J. Neurosci. Res. 85: 2833-2838.
45. Saksena S, Sun J, Chu T, Emr SD. 2007. ESCRTing proteins in the endocytic pathway. Trends Biochem. Sci. 32: 561-573.
46. Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. 2009. Functional reconstitution of ESCRT-III assembly and disassembly. Cell 136: 97-109.
47. Shim S, Kimpler LA, Hanson PI. 2007. Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 8: 1068-1079.
48. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114: 689-699.
49. Teis D, Saksena S, Emr SD. 2008. Ordered assembly of the ESCRT-III complex on endosomes is required to sequester cargo duringMVBformation. Dev. Cell 15: 578-589.
50. Tsang HT, et al. 2006. A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 88: 333-346.
51. Usami Y, Popov S, Gottlinger HG. 2007. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J. Virol. 81: 6614-6622.
52. VerPlank L, et al. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U. S. A. 98: 7724-7729.
53. von Schwedler UK, et al. 2003. The protein network of HIV budding. Cell 114: 701-713.
54. Weiss ER, Gottlinger H. 2011. The role of cellular factors in promoting HIV budding. J. Mol. Biol. 410: 525-533.
55. Wollert T, Hurley JH. 2010. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464: 864-869.
56. Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. 2009. Membrane scission by the ESCRT-III complex. Nature 458: 172-177.
57. Zamborlini A, et al. 2006. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc. Natl. Acad. Sci. U. S. A. 103: 19140-19145.
58. Zhai Q, et al. 2008. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 15: 43-49.
59. Zhao M, Li XD, Chen Z. 2010. CC2D1A, a DM14 and C2 domain protein, activates NF-kappaB through the canonical pathway. J. Biol. Chem. Vasanth11 285: 24372-24380.